What were Rossari Biotech Ltd's latest quarterly results?
Rossari Biotech Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: +35.3%
- Revenue Growth YoY: +18.1%
- Operating Margin: 11.0%
Rossari Biotech Ltd: Stock Analysis & Fundamentals
Data from 2w agoRossari Biotech Ltd (Seeds/Tissue Culture/Bio Technology) — fundamental analysis, earnings data, and key metrics. PE: 17.8. ROE: 11.8%. This stock is not currently in the Nifty 500 momentum outperformers list.
Rossari Biotech Ltd Key Facts
What's Happening
💪Debt reduced 19% YoY — balance sheet strengthening
🌐FII stake decreased 1.0% this quarter
Key Numbers
Current Price
₹479
Dividend Yield
0.10%
Market Cap
2.7K Cr
Valuation
N/AOther Top Seeds/Tissue Culture/Bio Technology Stocks Beating Nifty 500
Frequently Asked Questions: Rossari Biotech Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Rossari Biotech Ltd's current PE ratio?
Rossari Biotech Ltd's current PE ratio is 17.8x.
- Current PE: 17.8x
- Market Cap: 2.7K Cr
- Dividend Yield: 0.10%
What is Rossari Biotech Ltd's price-to-book ratio?
Rossari Biotech Ltd's price-to-book ratio is 2.0x.
- Price-to-Book (P/B): 2.0x
- Book Value per Share: ₹241
- Current Price: ₹479
Is Rossari Biotech Ltd a fundamentally strong company?
Rossari Biotech Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 15.0%
Is Rossari Biotech Ltd debt free?
Rossari Biotech Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹436 Cr
What is Rossari Biotech Ltd's return on equity (ROE) and ROCE?
Rossari Biotech Ltd's return ratios over recent years
- FY2024: ROCE 18.0%
- FY2025: ROCE 16.0%
- FY2026: ROCE 15.0%
Is Rossari Biotech Ltd's cash flow positive?
Rossari Biotech Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹65 Cr
- Free Cash Flow (FCF): ₹-154 Cr
- CFO/PAT Ratio: 44% (weak cash conversion)
What is Rossari Biotech Ltd's dividend yield?
Rossari Biotech Ltd's current dividend yield is 0.10%.
- Dividend Yield: 0.10%
- Current Price: ₹479
Who holds Rossari Biotech Ltd shares — promoters, FII, DII?
Rossari Biotech Ltd's shareholding pattern (Mar 2026)
- Promoters: 68.2%
- FII (Foreign): 2.2%
- DII (Domestic): 18.2%
- Public: 11.5%
Is promoter holding increasing or decreasing in Rossari Biotech Ltd?
Rossari Biotech Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 68.2% (Mar 2026)
- Previous Quarter: 68.2% (Dec 2025)
- Change: 0.00% (stable)
Is Rossari Biotech Ltd a new momentum entry or an established outperformer?
Rossari Biotech Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Rossari Biotech Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Rossari Biotech Ltd may be worth studying
- Cash flow is positive — CFO ₹65 Cr
What is the investment thesis for Rossari Biotech Ltd?
Rossari Biotech Ltd investment thesis summary:
What is the future outlook for Rossari Biotech Ltd?
Rossari Biotech Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.